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Natural killer (NK) cells play an important role in the defense against viral infections. Acti-
vation of resting NK cells is tightly controlled by the balance of surface inhibitory and
activating receptors and aided by cytokines released by accessory cells along the anti-viral
response. On the other hand, NK cells express functional pattern recognition receptors
(PRRs) whose function has been mostly addressed by the use of synthetic agonists.
The present study was undertaken to investigate whether NK cells could directly recog-
nize a complex pathogen such as Human Cytomegalovirus (HCMV). Exposure of primary
human NK cells to HCMV (TB40/E strain) induced the expression of CD69, promoted
IFNγ secretion, and increased their cytotoxic activity against HCMV-infected autologous
monocyte-derived dendritic cells. The divergent response induced by infective and UV-
inactivated virions indicated the involvement of different NK cell sensors in the recognition
of HCMV. The fact that NK cell activation could be partially prevented by blocking mAb
specific for IFNAR and TLR2, together with the induction of IFNβ mRNA, supported the
involvement of IFNβ andTLR2 in the response to HCMV.Thus, our data indicate that simul-
taneous activation of several PRRs leads to the autonomous priming of NK cell effector
functions and could be a previously unappreciated mechanism presumably contributing to
the control of HCMV infection.
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INTRODUCTION
Natural killer (NK) cells provide an important first line of defense
against viral pathogens. NK cells participate in the viral clear-
ance by lysing infected cells and through the production of IFNγ
and TNFα which exert a non-cytolytic control of the infection
and modulate the induction of protective specific responses. Acti-
vation of NK cells is tightly controlled by the balance between
germ-line encoded inhibitory and activating receptors (Lanier,
2008) and modulated by the action of innate cytokines (Biron
et al., 1999). More recently, a role for pathogen-associated pattern
recognition receptors (PRRs) as regulators of the NK cell biology
has emerged. Initial studies based on mRNA detection on human
NK cell extracts, described TLR1 as the highest expressed, fol-
lowed by moderate levels of TLR2, TLR3, TLR5, and TLR6, and
low levels of TLR4, TLR7, TLR8, and TLR9 mRNA (Hornung
et al., 2002; Chalifour et al., 2004; Hart et al., 2005; Gorski et al.,
2006; Marcenaro et al., 2008). TLR2, TLR3, TLR7, and TLR9 have
been shown to be intracellular in human NK cells (Roda et al.,
2005; Eriksson et al., 2006; Girart et al., 2007; Marcenaro et al.,
2008),although surface expression has also been reported for TLR2
and TLR3 (Becker et al., 2003; Hart et al., 2005). Generally, expo-
sure of primary NK cells to individual synthetic Toll-like receptor
(TLR) agonists did not enhance NK cell effector functions unless
combined with cytokines such as IL-12 or type I IFNs, yet con-
flicting data can also be found (Sivori et al., 2004; Hart et al., 2005;
Roda et al., 2005; Eriksson et al., 2006; Girart et al., 2007; Duluc
et al., 2009). Activation of TLR2, TLR7/8 promotes the secretion
of IFNγ while having little effect in NK cell cytotoxic responses
(Hart et al., 2005; Girart et al., 2007); in contrast, TLR9 signaling
induces the expression of activation markers and enhances Ab-
dependent cytotoxicity (Hornung et al., 2002; Sivori et al., 2004;
Roda et al., 2005; Girart et al., 2007). One of the strongest agonist
for NK cell function is polyI:C which in combination with IL-2 or
IL-12 promotes both IFNγ and cytotoxic responses through the
secretion of IFNβ (Sivori et al., 2004; Hart et al., 2005; Girart et al.,
2007; Duluc et al., 2009). Recently, sensing of poly I:C in NK cells
has been shown to mostly depend on RIG-1-like receptors (Perrot
et al., 2010), introducing cytosolic PRRs in the regulation of NK
cell biology. Indeed, NK cells express functional NOD-2, NRLP3,
Mda5, and RIG-1(Athie-Morales et al., 2008; Duluc et al., 2009;
Perrot et al., 2010).
To date, few studies have addressed the consequences of
pathogen sensing by NK cells. Interaction of human NK cells with
Mycobacterium bovis involved TLR2 and triggered NK cell activa-
tion (Marcenaro et al., 2008). NK cells have been shown to exhibit
direct microbicidal activity against Cryptococcus neoformans (Marr
et al., 2009). Remarkably, direct recognition of vaccinia virus by
TLR2 in NK cells was necessary for the efficient control of this
infection in a murine model, highlighting the importance of NK
cell pathogen recognition in vivo (Martinez et al., 2010).
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The contribution of NK cells in the immune response to viruses
is evidenced by the fact that patients with NK cell deficiencies are
susceptible to recurrent herpesviral infections, including Human
Cytomegalovirus (HCMV; Biron et al., 1989; Orange and Ballas,
2006). HCMV is an enveloped dsDNA virus which in vitro can pro-
ductively infect fibroblasts and, less efficiently, endothelial, and dif-
ferentiated myelomonocytic cells (Mocarski and Courcelle, 2001).
Cytomegalovirus infection activates the innate immune system
through both TLR-dependent and -independent pathways. Mice
strains harboring specific deletions evidenced the participation of
TLR2 and TLR9 in the recognition of MCMV envelope glycopro-
teins and viral DNA, respectively (Krug et al., 2004; Tabeta et al.,
2004; Szomolanyi-Tsuda et al., 2006; Zucchini et al., 2008). TLR3
and TLR7 are also involved in sensing CMV (Tabeta et al., 2004;
Zucchini et al., 2008) although it is not clear whether they are acti-
vated during initial infection or later during the viral replication
cycle. In humans, HCMV glycoproteins gB and gH activate TLR2
signaling (Boehme et al., 2006). CMV also stimulates cytosolic
DNA sensors such as DAI/ZBP1 in human fibroblasts (DeFilippis
et al., 2010) and the AIM2 inflammasome along MCMV infection
(Rathinam et al., 2010). Epidemiological data also supports the
involvement of TLR2 and TLR9 in HCMV sensing. Three genetic
studies have identified specific single nucleotide polymorphisms
in TLR2 and TLR9 genes which are highly predictive of susceptibil-
ity to HCMV infection/reactivation in adult recipients of liver and
allogeneic stem cell transplants, respectively (Kijpittayarit et al.,
2007; Carvalho et al., 2009; Kang et al., 2012).
The present study was undertaken to investigate the conse-
quences of the direct interaction between NK cells and a complex
pathogen such as HCMV. We provide data supporting the capacity
of NK cells to directly sense HCMV, identifying some of the mech-
anisms underlying this process, and dissecting the consequences of
this interaction on NK cell function. Our results support that the
simultaneous engagement of different PRRs on NK cells by HCMV
leads to an accessory cell-independent enhancement of NK cell
effector mechanisms, likely contributing to the development of an
efficient response against the infection.
MATERIALS AND METHODS
ANTIBODIES AND FLOW CYTOMETRY ANALYSIS
FACS analysis was performed using monoclonal antibodies spe-
cific for the following surface molecules: CD56-allophycocyanin
(APC), CD3-Phycoerythrin (PE), CD19-PE, CD123-PE, CD14-
PE, CD1a-PE, CD69-PE, IFNγ-PE, CD107a-fluorescein isothio-
cyanate (FITC; BD Biosciences Pharmingen, San Diego, CA, USA).
Anti-NKp30 (clone AZ20), and -NKp46 (clone BAB281) mAbs
were kindly provided by Prof. A. Moretta (University of Genova,
Italy). MAb anti-CD16 (clone KD1) has been previously described.
Cells were pretreated with human aggregated IgG (10 µg/ml) to
block Fc receptors, and subsequently labeled with specific anti-
bodies. Cell viability was measured using the FITC Annexin V
Apoptosis Detection Kit II (BD Pharmingen, San Diego, CA, USA)
according to the manufacturer’s instructions.
For blocking experiments the following monoclonal antibodies
were used at saturating concentrations: antagonistic mAb specific
for TLR2 (clone T2.5; Meng et al., 2004) was kindly provided by Dr.
Carsten Kirschning (Institute of Medical Microbiology, University
of Duisburg-Essen, Essen, Germany). Blocking antibody against
IFN receptor chain 2 (IFNAR; clone MMHAR-2, IgG2a) was from
Calbiochem. An anti-myc mAb (9E10, IgG1) was used as negative
control.
NK CELL ISOLATION
PBMC were obtained from heparinized blood samples by separa-
tion on Ficoll-Hypaque gradient (Lymphoprep; Axis-Shield PoC
AS, Oslo, Norway). Samples were obtained with the informed
consent of the subjects and the study protocol was approved
by the institutional Ethics Committee (CEIC-IMAS). NK cell
purification was performed by negative selection using EasySep
Human NK Cell Enrichment kit (StemCell Technologies, Greno-
ble, France) according to the manufacturer’s recommendations.
HCMV PREPARATION AND NK CELL TREATMENT
Purified stocks of HCMV TB40/E strain (Sinzger et al., 1999;
kindly provided by Dr. Christian Sinzger, Institute for Medical
Virology, University of Tubingen, Tubingen, Germany) were pre-
pared as previously described (Muntasell et al., 2010). Briefly,
MRC-5 cells were infected at 0.1 moi and supernatants recov-
ered when maximum cytopathic effect was reached. Virus was
pelleted twice through a sorbitol cushion (20% d-sorbitol in TBS
(25 mM Tris-HCl, pH7.4, 137 mM NaCl) by centrifugation 90 min
at 27,000× g at 15˚C, resuspended in serum-free DMEM, and
titered by standard plaque assays on MRC-5 cells. Inactivation
of viral stocks was achieved by UV-light using an UV-crosslinker
(Biorad GS genelinker UV chamber). A fraction of viral stocks was
passed through 0.1 µm filter to eliminate viral particles. Viral UV-
light inactivation and the absence of infectious virus in filtered
viral stocks were confirmed by treating the MRC-5 fibroblast cell
line with the viral preparations, followed by detection of the viral
IE-1/IE-2 antigen with a mouse anti-CMV mAb (clone mab810,
Millipore). No infected cells could be detected in MRC-5 monolay-
ers incubated with UV-inactivated TB40/E or filtered viral stocks.
In contrast, IE-1 nuclear staining was observed in 100% of MRC-5
cells treated with TB40/E.
Isolated NK cells were cultured in complete RPMI medium
supplemented with 200 µ/ml rhIL-2 (unless noted in the figure) in
the presence or absence of HCMV TB40/E strain (moi 5–10, based
on NK cell number), and CD69 expression was monitored after
24 h by flow cytometry. For inhibition of TLR-two-dependent and
type I IFN-dependent activity, NK cells were incubated with an
anti-TLR2 Ab (T2.5), anti-IFNAR Ab (MMHAR-2), or a control
Ab for 1 h before the addition of HCMV. Inhibition of endosomal
maturation was achieved by treating NK cells with Bafilomycin A1
(25 nM; Sigma, Saint Louis, MO, USA) for 30 min before HCMV
addition and during the 8 h of co-culture.
FUNCTIONAL ASSAYS
Supernatants of non-treated or HCMV-exposed NK cells were
collected after 24 and 48 h and frozen at −80˚C. Thawed samples
were assayed by ELISA for IFNγ and IFNα (Bender MedSystems,
Vienna, Austria).
Natural killer cell degranulation was measured by the CD107a
mobilization assay (Alter et al., 2004). NK cells were non-treated
or exposed to HCMV TB40/E strain. After 24 h NK cells were har-
vested, washed and incubated with 1 µg anti-CD107a-FITC and
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5 ng/ml monensin for 4 h at 37˚C with 10% CO2, either alone or
in the presence of autologous HCMV-infected monocyte-derived
Dendritic Cells (moDC) or the K562 erythroleukemia cell line.
P815 murine mastocytoma cell line was pre-incubated with anti-
NKp46, anti-NKp30, and anti-CD16 mAb, and used as target in
redirected degranulation assays. After co-culture, cells were stained
with anti-CD56 mAb and analyzed by flow cytometry.
MoDCs were generated as described previously (Magri et al.,
2011). After 5 days, cells were infected with HCMV TB40/E strain
(moi 50–100). At 48 h post-infection DC were harvested and
used as targets cells in degranulation assays. To monitor the
infection rate, cells were washed twice and cytospin preparations
were stained by indirect immunofluorescence with a mouse anti-
CMV IE-1/IE-2 monoclonal antibody (clone mab810, Chemicon,
Temecula, CA, USA).
MEASUREMENT OF mRNA LEVELS
For RNA and cDNA preparation, NK cells (2× 106) were isolated
by negative selection and exposed to TB40/E HCMV strain (moi 5–
10) in combination with IL-12 (10 ng/ml) for 6 and 12 h. Cells were
lysed in RLT buffer (300 µl, RNeasy system, QIAGEN, 74104) and
total RNA was isolated using the same system. RNA was quantified
in a NanoDrop®(ND-1000 Spectrophotometer) and 250 ng were
retro-transcribed to cDNA using SuperScript III reverse transcrip-
tase and random primers (Invitrogen). For real-time quantitative
PCR (RT-qPCR), LightCycler 480 SYBR Green I Master (Roche)
and a Roche LightCycler 480 detection system (Roche) were used
following the instructions provided by the manufacturers. Samples
were normalized to GAPDH mRNA levels using the LightCycler
480 Software, version 1.5. Primer sequences for the PCR reactions
were: 5′-GCC ATC AAT GAC CCC TTC ATT-3′ (Forward) and
5′-TTG ACG GTG CCA TGG AAT TT-3′ (Reverse) for GAPDH;
5′-AAA CTC ATG AGC AGT CTG CA-3′ (Forward) and 5′-AGG
AGA TCT TCA GTT TCG GAG G-3′ (Reverse) for IFNβ (DeFil-
ippis et al., 2010); 5′-GCA GGT CAT TCA GAT GTA GCG G-3′
(Forward) and 5′-TGT CTT CCT TGA TGG TCT CCA CAC-3′
(Reverse) for IFNγ (Janson et al., 2008).
STATISTICAL ANALYSIS
Statistical analysis was performed by the Student t -test using
GraphPad Prism 5 software. Results were considered significant
at the two-sided P level of 0.05.
RESULTS
DIRECT RECOGNITION OF HCMV BY NK CELLS INDUCES CD69
EXPRESSION AND SYNERGIZES WITH IL-12 IN THE PRODUCTION OF
IFNγ
To assess whether NK cells could directly recognize HCMV we set
up an experimental culture system including highly purified pri-
mary NK cells and viral particles of the TB40/E HCMV viral strain.
Purity of the NK cells obtained was >98% as evaluated by flow
cytometry including an anti-CD56 as an NK cell marker against
a panel of mAbs including anti-CD19, -CD14, -CD3, -CD1a, and
-CD123 as lineage exclusion cocktail (Figure 1A). In all experi-
ments, NK cells were stimulated with 5–10 infective viral particles
per cell (from now on referred as HCMV moi). We initially mon-
itored the up-regulation of the early activation marker CD69 by
flow cytometry and the production of IFNγ in cell-free super-
natants by ELISA. IL-12 (10 ng/ml) was added to promote IFNγ
production. After 24 h, HCMV and IL-12, alone or in combination,
induced the expression of CD69 on NK cells (Figure 1B). HCMV-
induced expression of CD69 was mostly restricted to CD56dim
NK cells, at variance with the general up-regulation induced by
IL-12 treatment. On the other hand, incubation of NK cells with
HCMV resulted in a modest production of IFNγ, but significantly
enhanced the secretion induced by IL-12, as measured by ELISA
in the cell-free supernatant after 24 and 48 h (Figure 1C).
FIGURE 1 | Direct HCMV recognition induced CD69 expression in NK
cells and enhanced IL-12-induced IFNγ secretion. Purity of NK cells
isolated by negative selection from peripheral blood of healthy donors was
assessed by multicolor flow cytometry including anti-CD56-APC and
anti-CD3-PE, -CD19-PE, -CD14-PE, -CD1a-PE, -CD123-PE as lineage
exclusion cocktail (A). Purified NK cells were left untreated (NT) or
co-cultured with HCMV (MOI 5–10) for 24 and 48 h in the presence or
absence of IL-12 (10 ng/ml) and IL-2 (200 µ/ml). At 24 h, CD69 expression
on NK cells was tested by a double staining with anti-CD56-APC and
CD69-PE specific mAbs by flow cytometry (B). IFNγ was measured by
ELISA in cell-free supernatants harvested at 24 and 48 h (C). Intracellular
IFNγ was monitored on NK cells co-cultured for 24 h with the different
stimuli. Brefeldin A was added for the last 5 h and IFNγ staining was
analyzed by flow cytometry. Inserts depict the proportion of IFNγ positive
NK cells (D). In all cases, data correspond to results from a representative
donor out of at least three tested.
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Intracellular IFNγ staining showed that HCMV moderately
increased the frequency of NK cells producing IFNγ in response
to IL-12. The higher intensity of the IFNγ staining in NK cells
treated with both stimuli indicated an enhancement or a more
sustained IFNγ response per cell (Figure 1D). In contrast to the
low IFNγ secretion detected by ELISA (Figure 1C), a proportion of
the NK cells incubated with the virus contained intracellular IFNγ
(Figure 1D). Differences in IFNγ production were not related to
NK cell viability that was shown to be similar among the con-
ditions tested, by AnnexinV/Propidium Iodide staining (data not
shown).
Since previous experiments included IL-2 (200 µ/ml), we next
assessed whether NK cells would equally respond to HCMV in
the absence of IL-2. As shown in Figure 2, HCMV-induced CD69
up-regulation and enhanced IFNγ secretion independently of IL-2
signaling; nonetheless, IL-2 magnified the secretion of IFNγ in all
conditions.
Overall, our data indicated that NK cells could directly rec-
ognize HCMV. Sensing of the virus promoted the expression of
CD69 and enhanced the secretion of IFNγ in response to IL-12,
regardless of IL-2 presence.
DIRECT INTERACTION WITH HCMV INCREASES NK CELL
DEGRANULATION AGAINST HCMV-INFECTED CELLS
Degranulation assays were performed to evaluate whether direct
recognition of HCMV would also influence NK cell cytotoxicity
against HCMV-infected targets. Purified NK cells were incubated
with HCMV in the presence or absence of IL-12. After 24 h, cells
were harvested, washed to eliminate remaining viral particles and
incubated with autologous moDC infected with HCMV as tar-
gets or the K562 human leukemia cell line as a positive control.
The rate of moDC infection ranged between 40–60% depending
on the donor. CD107a mobilization assays were used to mon-
itor the proportion of NK cells secreting cytolytic granules, As
shown in Figures 3A,B NK cells preincubated with HCMV dis-
played an increased degranulation against HCMV-infected moDC
compared to non-treated NK cells, independently of IL-12, while
showing similar response against K562 cells (Figure 3C). The
NKp46 activating receptor has been previously shown to mediate
the recognition of HCMV-infected myelomonocytic cells (Magri
et al., 2011; Romo et al., 2011). In order to assess whether sensing
of HCMV would modulate the activity of specific NK cell activat-
ing receptors, we set up P815-based redirected assays to analyze the
degranulation triggered through NKp46, NKp30, and CD16. Puri-
fied NK cells pretreated with HCMV or untreated were confronted
to P815 targets coupled to specific mAbs. As shown in Figure 3D,
HCMV-primed NK cells tended to display an enhanced NKp46-
and CD16-mediated degranulation in comparison to mock treated
NK cells while comparably responding to NKp30 triggering.
Altogether, these results indicate that sensing of HCMV by
NK cells facilitated their activation in response to HCMV-
infected moDC.
HCMV RECOGNITION ACTIVATES SEVERAL NK CELL SENSOR
MECHANISMS INVOLVING THE PRODUCTION OF TYPE I IFNs AND TLR2
To further characterize the NK cell response to HCMV, CD69
expression was monitored in freshly purified NK cells cultured
FIGURE 2 | IL-2 influence on the recognition of HCMV by NK cells.
Freshly purified NK cells were incubated with HCMV (MOI 5) and IL-12
(10 ng/ml) in the presence or absence of 200 µ/ml of IL-2. After 24 h, CD69
expression was analyzed by flow cytometry (A) and the secretion of IFNγ
was monitored in cell-free supernatants by ELISA (B,C). Bar graphs show
the secretion of IFNγ of a representative experiment (B). Scattered plot
display results of the three donors independently tested (C). Statistical
analysis was performed by the Student t -test. Mean±SEM are indicated
(*p < 0.05; **p < 0.01).
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FIGURE 3 | Direct HCMV recognition enhances NK cell degranulation
against HCMV-infected moDC. Freshly purified NK cells were incubated
alone (NT), or with IL-12 and/or HCMV TB40/E. After 24 h, cells were washed
and the degranulation of NK cells was assessed after 5 h incubation with
mock or HCMV TB40/E infected moDC (A,B), and K562 (C) (E:T, 4:1). NK cell
degranulation was monitored by CD107a staining analyzed by flow cytometry.
(A) Bar graphs represent the percent of NK cells positive for CD107a in the
absence of target cell (gray bars), in front of mock moDC (empty bars), or
HCMV-infected moDC (black bars) from one representative donor. (B) Bar
graph displaying the mean±SEM of the normalized degranulation. Data in
each experiment were normalized to the response of non-treated NK cells
incubated with HCMV-infected DC (100%). Statistical analysis by the Student
t -test (**p < 0.01; ***p < 0.0001) (C) Bar graph showing the mean±SEM of
the percent in degranulation to K562 of three donors tested (D) Bar graph
displaying the mean±SEM frequency of CD56+CD107a+ of non-treated
(empty bars) or HCMV treated (gray bars) NK cells responding to P815 cells
coupled to mAbs specific for NKp46 (Bab281), NKp30 (az20), CD16 (KD1), and
anti-myc as control IgG in three independent experiments.
FIGURE 4 | NK cell activation in response to infective and UV-inactivated
HCMV. Freshly purified NK cells were incubated with infective-,
UV-inactivated- HCMV, or filtered viral supernatant in the presence or absence
of IL-12 (10 ng/ml). After 24 h, CD69 expression was analyzed by two-color
flow cytometry with specific mAbs anti-CD69 and -CD56 (A) and IFNγ
secretion was measured by ELISA in cell-free supernatants (B). Bar graphs
correspond to the mean±SEM of the results obtained with the indicated
donors. Statistic analysis by the Student t -test (*p < 0.05; **p < 0.01).
with infective-, UV-inactivated HCMV, and filtered viral super-
natant for 24 h. Only infective but not UV-inactivated virus or
supernatant devoid of viral particles induced CD69 expression
on NK cells (Figure 4A). To assess IFNγ secretion, purified NK
cells were stimulated in the same conditions in the presence of IL-
12 (10 ng/ml). Enhanced secretion of IFNγ was mostly sustained
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by the infective form of HCMV, UV-inactivated virions showed
a partial effect while the filtered viral supernatant did not sig-
nificantly modify the amount of IFNγ secreted in response to
IL-12 (Figure 4B). Thus, HCMV-induced NK cell activation was
absolutely dependent on the presence of viral particles, ruling
out the presence of other pathogen-associated molecular pat-
terns or damage-associated molecular patterns in the virus stock
supernatant.
The different response to infective and UV-inactivated virus
suggested that HCMV triggered at least two distinct NK cell sen-
sor mechanisms. Since TLR2 is one of the major HCMV sensors,
we investigated whether it could be involved in the recognition
of this virus by NK cells. Staining of freshly isolated PBMC
with anti-TLR2 in combination with anti-CD56 and anti-CD3
showed that TLR2 expression was intracellular in NK cells, being
barely detectable on the cell surface. In contrast, monocytes dis-
played TLR2 at the cell surface (Figure 5A). To test whether the
endocytic pathway was involved in HCMV sensing, endosome
maturation was blocked by adding bafilomycin A1, an inhibitor
of the vacuolar-type H+-ATPase, along NK cell treatment with
HCMV. Bafilomycin A1 prevented the increase in IFNγ triggered
by both infective and Uv-inactivated virus while keeping unaltered
the secretion in response to IL-12 (Figure 5B).
Given that type I IFNs have been previously shown to induce
CD69 expression in NK cells (Waddell et al., 2010; Magri et al.,
2011), we used blocking mAb for TLR-2 and IFNAR to test their
participation in the NK cell response to HCMV. CD69 expression
and the secretion of IFNγ were analyzed after treating NK cells with
HCMV and IL-12 in the presence of blocking reagents. As shown in
Figures 6A,B, HCMV-induced up-regulation of CD69 was com-
pletely prevented by blocking the type I IFN receptor, while the
presence of TLR2 blocking mAb had a minor effect, compara-
ble to control IgG. In contrast, HCMV-induced secretion of IFNγ
was partially prevented by both anti-TLR2 and -IFNAR-blocking
mAbs (Figure 6C). The expression of CD69 and the secretion of
IFNγ in NK cells stimulated with IL-12 was comparable in the
presence of blocking mAb (Figures 6A–C).
The analysis of IFNγ and IFNβ mRNA in purified NK cells
showed that IL-12 was initially driving the increase in IFNγ mRNA
(6 h). After 18 h, HCMV enhanced IFNγ mRNA levels in both IL-
12-treated and non-treated NK cells (Figure 7). HCMV but not
IL-12 triggered IFNβ mRNA expression in NK cells, detected at
6 h and increasing after 18 h of treatment (Figure 7). IFNα was
not detected in the supernatants (data not shown), pointing out
the role of IFNβ in the observed type I IFN-dependent activation
of NK cells.
Taken together, our results indicate that NK cell recognition of
HCMV is mediated by at least two different sensor mechanisms.
Infective HCMV triggers a type I IFN response, likely driven by
autocrine IFNβ production, which induces CD69 surface expres-
sion, while TLR2 participates in the recognition of the viral particle
promoting IFNγ secretion.
DISCUSSION
To date, the NK cell response to HCMV has been character-
ized in animal models or in in vitro culture systems that do
not allow assessing whether the direct interaction between NK
FIGURE 5 | IntracellularTLR2 localization and effect of Bafilomycin A1
treatment in HCMV sensing by NK cells. PBMC samples were analyzed
by three color flow cytometry with mAb specific for TLR2 or a control IgG in
combination with anti-CD3-PerCP and anti-CD56-APC. For intracellular
staining PBMC were fixed and permeabilized prior to the incubation with
mAbs. Dot plots display the staining for TLR2 in the NK cell gate
(CD56+CD3-) and in monocytes gated by forward and side light scatter.
Data correspond to one representative donor out of three analyzed (A).
IFNγ secretion was measured by ELISA in supernatants from NK cells
incubated with IL-12 and infective- or UV-inactivated HCMV, in the presence
or absence of Bafilomycin A1 (Bfa A1, 25 nM). Empty and gray bars
correspond to non-treated (NT) and Bfa A1 treated cultures. Bar graph
showing the mean±SEM of the data obtained from six donors (B). Statistic
analysis by the Student t -test (*p < 0.05; **p < 0.01; ***p < 0.0001).
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FIGURE 6 | Effect of IFNAR andTLR2 blockade on NK cell activation.
Freshly purified NK cells were left untreated or incubated with HCMV and
IL-12 in the presence or absence of antagonizing antibodies for TLR2 and
IFNAR. CD69 expression (A,B) and IFNγ secretion (C) were monitored at
24 h by flow cytometry and ELISA, respectively. (A) Histograms depict
surface CD69 expression on NK cells in the absence of blocking mAbs (NT,
gray profiles) or when cultures included anti-IFNAR (bold lines), anti-TLR2
(thin lines), or control IgG (dashed lines). Results from one representative
donor are shown. (B) Bar graph showing the mean±SEM of the
normalized expression of CD69. Data in each experiment were normalized
to the CD69 expressed by NK cells exposed to HCMV in the absence of
blocking reagents (100%). (C) Bars graph displaying the mean±SEM of
IFNγ secretion in five donors. Statistic analysis by the Student t -test
(*p < 0.05; **p < 0.01; ***p < 0.0001).
cells and HCMV may influence the anti-viral response. Given
the fact that NK cells express functional PRRs, we developed
an experimental system to examine the capacity of NK cells to
sense HCMV. The data demonstrate that direct HCMV recog-
nition results in TLR2 activation and the production of type
I IFNs leading to the priming of NK cells as evidenced by (i)
induced expression of the CD69 activation marker, (ii) enhanced
secretion of IFNγ and, (iii) increased degranulation against
HCMV-infected moDC.
The interaction of NK cells with HCMV triggered at least
two sensor mechanisms distinguished by the response to infec-
tive and UV-inactivated viral particles. Recognition of infective
HCMV-induced the expression of CD69 in CD56dim NK cells.
In agreement with previous reports (Waddell et al., 2010; Magri
et al., 2011), IFNAR-blocking mAbs prevented the expression of
this early activation marker, indicating that HCMV recognition
by resting NK cells triggers the production of type I IFNs. The
expression of IFNβ mRNA supported this cytokine as the likely
candidate for the autocrine effect. Type I IFN responses in MCMV
infection partially depend on TLR2 activation (Szomolanyi-Tsuda
et al., 2006; Barbalat et al., 2009). In our experimental system, the
inefficacy of anti-TLR2 mAb in preventing HCMV-induced CD69
up-regulation together with the failure of UV-inactivated virions
to induce CD69 expression, argued against the involvement of
any TLR in the type I IFN response of NK cells to HCMV. The
requirement of infective virions for CD69 up-regulation suggests
that HCMV may enter into NK cells, initiating its transcriptional
program and thus, allowing the activation of cytosolic PRRs. Cel-
lular receptors such as heparan sulfate proteoglycans and the
β1-integrin VLA-6 found in resting NK cells (Perez-Villar et al.,
1996) could, theoretically, mediate the entry of HCMV (Comp-
ton, 2004). Yet, according with the resistance of lymphocytes to
HCMV productive infection, we did not detect nuclear accumula-
tion of the immediate early HCMV proteins IE-1/IE-2 in NK cells
co-cultured with infective virions (data not shown; Rice et al.,
1984; Nowlin et al., 1991). Our results do not allow to pinpoint
which cytosolic sensor/s are involved in the HCMV-dependent
IFNβ response but likely candidates are Mda5 or RIG-1, reported
to be expressed in NK cells and to induce IFNβ secretion in
response to polyI:C, a synthetic analog to viral dsRNA (Duluc
et al., 2009; Perrot et al., 2010). Whether any resting NK cell
is susceptible to HCMV entry or whether a particular NK cell
subset supports the IFNβ response to HCMV, deserves further
attention.
On the other hand, simultaneous addition of IL-12 and HCMV
to NK cells, promoted a substantial IFNγ secretion, exceeding the
effect of IL-12 alone. In this case, antagonistic anti-TLR2 mAbs
partially blocked the synergism, indicating the involvement of this
TLR in the recognition of HCMV by NK cells. Indeed, HCMV
envelope glycoproteins gB and gH bind TLR2, triggering NF-kB
activation in other cell types (Boehme et al., 2006). The fact that
UV-inactivated viral particles also enhanced IL-12-induced IFNγ
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secretion further supports the idea that structural virion com-
ponent/s are being recognized by NK cells. Although, TLR2 was
barely detected on the NK cell surface by flow cytometry, intracel-
lular TLR2 showed a consistent staining, agreeing with a previous
report (Eriksson et al., 2006). Consistent with the likely TLR2 loca-
tion in NK cell endosomes, an inhibitor of endosomal maturation
(i.e., Bafilomycin A1) prevented HCMV-dependent IFNγ secre-
tion. As TLR2 recognizes hydrophobic PAMPs, it is possible that
acidification of the endocytic pathway would allow hindered pep-
tides in gB to become exposed and visible to TLR2. Considering
the specialized role of NK cells in the control of viral infections,
it is tempting to speculate that intracellular TLR2 could serve as
a mechanism to ensure its activation in response to intracellular
pathogens. In this line, TLR2 has also been involved in the recog-
nition of hepatitis C virus, lymphocytic choriomeningitis virus,
measles virus, vaccinia virus, herpes simplex virus, and M. bovis
by NK cells and other cell types (Bieback et al., 2002; Chang et al.,
2007; Zhu et al., 2007; Marcenaro et al., 2008; Martinez et al., 2010;
Leoni et al., 2012).
Human Cytomegalovirus recognition by NK cells resulted in
the priming of at least two important anti-viral effector mecha-
nisms: IFNγ secretion and cytotoxicity against infected cells. Both
TLR2 and type I IFNs enhanced the secretion of IFNγ, as indi-
rectly shown by the partial blockade with antagonistic mAbs for
TLR2 and IFNAR, respectively. Engagement of TLR2 may enhance
IFNγ secretion through the activation of NF-kB and Ik-Bzeta, sim-
ilarly to IL-18R activation (Akira et al., 2006). The late increase
of HCMV-dependent IFNγ mRNA levels is reminiscent of the
kinetics of IFNγ production upon IL-12+IL-18 stimulation in
NK cells (Miyake et al., 2010; Kannan et al., 2011). Of note, two
genetic studies have shown that specific TLR2 polymorphisms
condition the probability to develop CMV disease in transplant
recipients (Kijpittayarit et al., 2007; Kang et al., 2012). Assessing
whether TLR2 polymorphisms could explain the important inter-
individual variability in the magnitude of IFNγ secreted by NK
cells in response to HCMV deserves attention. On the other hand,
the partial blockade exerted by IFNAR-blocking mAb supports the
participation of autocrine IFNβ in the secretion of IFNγ. Signal-
ing through IFNAR could directly cooperate with IL-12 (Duluc
et al., 2009) or indirectly support IFNγ secretion by promoting
TLR expression (Miettinen et al., 2001).
Natural killer cell interaction with infective HCMV also facil-
itated the subsequent recognition and degranulation against
infected targets. This effect was independent of IL-12 and presum-
ably related to the autocrine effect of type I IFNs induced by the
virus. The requirement for type I IFNs stimulation on NK cells for
the development of efficient cytotoxic responses has been previ-
ously appreciated (Martinez et al., 2008), however, the underlying
mechanism remains largely unaddressed. It is known that type
I IFNs increase granzyme B, perforin, IFNγ, TNFα, and NKG2A
mRNA levels (Mori et al., 1998; Martinez et al., 2008), suppressing
two miRNA (miR-378 and miR30e) that negatively regulate per-
forin and granzyme B expression in resting NK cells (Wang et al.,
2012). Redirected degranulation assays suggested that NK cell
priming by HCMV enhanced NKp46-mediated activation, most
probably participating in the enhanced NK cell degranulation
against infected moDC, according to previous reports (Magri et al.,
FIGURE 7 | IFNγ and IFNβ mRNA in NK cells along co-culture with
HCMV. Real-time PCR was performed on mRNA isolated from purified NK
cells treated with IL-12 and HCMV TB40/E alone or in combination, for 6 and
18 h. Bar graphs indicate expression levels of IFNγ and IFNβ transcripts.
GAPDH was used to internally standardize the levels of gene expression.
Data are expressed as fold difference between non-treated cells (whose
levels of gene expression have been assumed as 1) and cells cultured with
different stimuli. Bar graphs include results obtained with NK cells purified
from three different donors (mean±SD). Statistic analysis by the Student
t -test (*p < 0.05; **p < 0.01; ***p < 0.0001).
2011; Romo et al., 2011). Whether the increase in the activity of
these particular activating receptors occurs as a consequence of
type I IFN signaling or by an alternative pathway triggered by
HCMV deserves further attention.
CONCLUSION
Physiologically, NK cells present in the inflammatory infiltrates of
HCMV active replication sites would have the chance of directly
encounter viral particles. Our data shows that the direct recogni-
tion of a complex pathogen such as HCMV activates complemen-
tary PRRs leading to the autonomous priming of NK cell effec-
tor functions, a mechanism likely contributing to the anti-viral
response.
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